Wave Life Sciences Ltd. WVE
Wave Life Sciences Ltd. statistics & valuation
Market cap$1.1B
P / S25.8×
P / B2.1×
Net margin-478.3%
Return on equity-39.4%
FCF margin-440.5%
Return on capital-39.6%
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating margin | -504.1% | -101.9% | -60.0% | -4459.3% | -310.1% | -763.9% | -1303.4% | -1106.7% | -2630.1% | -3752.2% |
| Net margin | -478.3% | -89.6% | -50.8% | -4434.7% | -298.4% | -746.7% | -1211.5% | -1017.4% | -2619.6% | -3748.1% |
| FCF margin | -440.5% | -140.3% | -18.1% | -3539.1% | -218.6% | -584.4% | -1202.2% | -227.6% | -2634.4% | -2524.7% |
| Return on assets | -32.0% | -27.5% | -20.9% | -110.5% | -59.1% | -53.7% | -68.1% | -49.6% | -56.1% | -33.8% |
| Return on equity | -39.4% | -46.3% | -145.1% | 358.9% | -376.2% | -181.1% | -303.8% | -199.9% | -73.0% | -41.4% |
| Current ratio | 6.47 | 2.89 | 1.26 | 1.38 | 2.53 | 1.90 | 1.57 | 1.56 | 8.27 | 12.50 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.